Chemir Establishes Cyanta Drug Development Services

Chemir Analytical Services, a Maryland Heights, Mo-based chemical analysis and testing company has announced the establishment of a new company dedicated to solely serving the pharmaceutical industry, Cyanta Drug Development Services.  Cyanta will specialize in providing testing services to pharmaceutical clients in support of their New Drug Applications (NDA), Abbreviated New Drug Applications (ANDA) and 510K Applications.  Cyanta's specialization in pharmaceutical services will include analytical development, stability and method validation programs, formulation and deformulation studies, extractables and leachables and custom synthesis.

Since 1959, Chemir Analytical Services has provided analytical services to many different industries. The pharmaceutical and medical device manufacturing communities recognized Chemir's talent for tackling complicated projects and providing customized solutions. The establishment of Cyanta grows out of Chemir's growing base of pharmaceutical and medical device clients.

"The Chemir Group has proven to be technically skilled, solutions oriented and customer responsive and I am pleased to see they are taking this next step to serving the pharmaceutical industry," said Michael Petteruti of Quigley Pharma upon hearing news of the creation of the new company.

The official launch for Cyanta is scheduled for the 2006 Association of American Pharmaceutical Scientists Annual Meeting and Exposition, to be held in San Antonio, Texas on Oct. 29 to Nov. 2.  In 2007, Cyanta will move into its own facility located directly next door to Chemir's laboratories in Maryland Heights.  Following renovation, the building will be dedicated to pharmaceutical and medical device analyses. 

Chemir Analytical Services
2672 Metro Blvd.
Maryland Heights MO 63043
800-659-7659
www.chemir.com
info@chemir.com